Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-sparing onco-anesthesia for pediatric cancer procedures
PACTR202008462414719Phase 3Recruiting
- Sponsor
- Mona Raafat Elghamry
- Start
- Aug 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of ketamine, propofol, dexmedetomidine, magnesium sulfate and fentanyl in cancer, sponsored by Mona Raafat Elghamry. Primary endpoint: total fentanyl consumption. Started Aug 2020; status: recruiting.
02
Drugs
ketaminepropofoldexmedetomidinemagnesium sulfatefentanyl
03
Conditions
cancer
Beyond the preview
Go deeper on PACTR202008462414719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202008462414719.